A pharmacist is warning patients not to treat the newly approved Wegovy tablet as a simple “needle-free” alternative to injections. They warned the once-daily pill has strict instructions, familiar GLP‑1 side effects and extra safety risks if people try to buy it online without proper checks.
The prescription-only medicine contains semaglutide and has been approved in the UK for weight loss and weight management, offering an oral form of a GLP‑1 treatment. Hira Malik, superintendent pharmacist at Oushk Pharmacy, said the practicalities are being overlooked by some patients who hear “tablet” and assume it’s straightforward.
Not a normal morning tablet
“The new Wegovy pill sounds simple because people are used to taking tablets,” she said. “But this is not a normal morning tablet you can take with coffee, breakfast, or your other medicines. It has strict instructions; it can still cause side effects, and switching from injections should never be treated as a DIY decision.
“The danger is that patients hear ‘needle-free’ and assume ‘easier’. For some people, a tablet may fit their routine well. For others, it could actually be easier to get wrong.”
She added: “We must remember that this is not just an over-the-counter ‘slimming pill’. It is a prescription medicine that should only be supplied after appropriate assessment by a qualified healthcare professional… The biggest danger is not the tablet itself, but poor information, rushed decisions and patients being made to feel that weight-loss medication is just another online purchase.”
Five things patients may not be told clearly enough
1) A pill still needs a full care plan
Malik said Wegovy tablets don’t remove the need for safe prescribing, monitoring and ongoing support. She said GLP‑1 treatment should be part of a wider plan that considers nutrition, hydration, protein and fibre intake, physical activity, side effects, dose changes and maintenance. While reduced appetite is part of how these medicines work, she warned that eating too little or skipping meals can leave people weak, tired, nauseous or light‑headed.
2) Fake Wegovy tablets could be harder to spot
Malik warned counterfeit weight-loss injections have already been identified in the UK — and tablets may create a different kind of risk because they can be easier to copy, ship and sell discreetly online. Counterfeit medicines, she said, can contain the wrong ingredient, too much or too little active ingredient, no active ingredient at all, or substances that should not be swallowed. She urged patients to be cautious about unusually low prices, no proper consultation, pressure selling, social media/marketplace sellers, poor packaging, spelling mistakes and missing pharmacy registration details.
3) Morning coffee (and breakfast) can interfere with absorption
A key hurdle, Malik said, is fitting the tablet into a real-life morning routine. She said the medicine needs to be taken on an empty stomach, swallowed whole with a small amount of plain water, then followed by at least 30 minutes before eating, drinking tea or coffee, or taking other oral medicines. Because semaglutide is difficult to absorb in the stomach, she said timing, food and drink can all affect how much the body takes in — and repeated slip-ups could mean patients don’t get the effect they expect.
4) Needle-free doesn’t mean side-effect free
Malik said some patients assume a tablet will be “gentler”, but the side-effect profile remains. She said nausea, diarrhoea, constipation, vomiting, indigestion or reflux can still happen, particularly when starting treatment or moving through dose changes. She added that severe or persistent abdominal pain, repeated vomiting, dehydration symptoms, fainting, or anything unusual should not be ignored.
5) You can’t switch from injections by matching dose numbers
Malik warned patients not to try to work out a tablet dose by comparing it to their injection dose. She said injections are fully absorbed, while oral tablets deliver only a small proportion of the drug, so the numbers don’t compare directly. Any change in formulation, dose or schedule should be made via a prescriber, taking into account medical history, side effects, current treatment and routine — and patients should not overlap treatments or follow switching advice from social media.
